WO2003040369A3 - Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines - Google Patents
Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines Download PDFInfo
- Publication number
- WO2003040369A3 WO2003040369A3 PCT/IB2002/004219 IB0204219W WO03040369A3 WO 2003040369 A3 WO2003040369 A3 WO 2003040369A3 IB 0204219 W IB0204219 W IB 0204219W WO 03040369 A3 WO03040369 A3 WO 03040369A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tumoral
- reversion
- apoptosis
- suppression
- medicines
- Prior art date
Links
- 230000001173 tumoral effect Effects 0.000 title abstract 4
- 206010034133 Pathogen resistance Diseases 0.000 title abstract 2
- 230000006907 apoptotic process Effects 0.000 title abstract 2
- 230000001629 suppression Effects 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003990 molecular pathway Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention concerns in particular novel sequences involved in the molecular pathways of tumoral suppression, tumoral reversion, apoptosis and/or viral resistance. The invention also concerns the use of said sequences for treatment against cancer, viral diseases, neurodegenerative diseases and for diagnostic purposes as well as for implementing methods for screening compounds to be tested. The invention further concerns methods for detecting and/or assaying the inventive sequences or their expression products in a biological sample.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR01/11981 | 2001-09-17 | ||
FR0111981 | 2001-09-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003040369A2 WO2003040369A2 (en) | 2003-05-15 |
WO2003040369A3 true WO2003040369A3 (en) | 2004-07-29 |
Family
ID=8867345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/004219 WO2003040369A2 (en) | 2001-09-17 | 2002-09-17 | Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2003040369A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003087372A2 (en) * | 2002-04-12 | 2003-10-23 | Molecular Engines Laboratories | Growth factor derived from hepatome and the use of the same |
US8163482B2 (en) | 2006-02-23 | 2012-04-24 | Nicholas Katsanis | BBS10 related diagnostic methods for Bardet-Biedl syndrome |
MY154507A (en) | 2012-03-19 | 2015-06-22 | Malaysian Palm Oil Board | Gene Controlling Shell Phenotype in Palm |
MY156871A (en) * | 2013-07-18 | 2016-04-07 | Malaysian Palm Oil Board | Detection methods for oil palm shell alleles |
NO344051B1 (en) * | 2017-05-04 | 2019-08-26 | Patogen As | Novel virus in Fish and Method for detection |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997017434A2 (en) * | 1995-11-09 | 1997-05-15 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
WO1997022695A2 (en) * | 1995-12-20 | 1997-06-26 | Fondation Jean Dausset-Ceph | Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
WO2000008147A1 (en) * | 1998-08-05 | 2000-02-17 | Molecular Engines Laboratories | Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
WO2001051670A2 (en) * | 2000-01-07 | 2001-07-19 | Curagen Corporation | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
WO2001057182A2 (en) * | 2000-01-31 | 2001-08-09 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
WO2001059063A2 (en) * | 2000-01-31 | 2001-08-16 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
-
2002
- 2002-09-17 WO PCT/IB2002/004219 patent/WO2003040369A2/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997017434A2 (en) * | 1995-11-09 | 1997-05-15 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
WO1997022695A2 (en) * | 1995-12-20 | 1997-06-26 | Fondation Jean Dausset-Ceph | Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
WO2000008147A1 (en) * | 1998-08-05 | 2000-02-17 | Molecular Engines Laboratories | Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
WO2001051670A2 (en) * | 2000-01-07 | 2001-07-19 | Curagen Corporation | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
WO2001057182A2 (en) * | 2000-01-31 | 2001-08-09 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
WO2001059063A2 (en) * | 2000-01-31 | 2001-08-16 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
Non-Patent Citations (6)
Title |
---|
BRENNER SYDNEY ET AL: "Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays.", NATURE BIOTECHNOLOGY, vol. 18, no. 6, June 2000 (2000-06-01), pages 630 - 634, XP002199492, ISSN: 1087-0156 * |
DATABASE GSN [online] 23 January 2002 (2002-01-23), XP002237861, Database accession no. ABA16909 * |
DATABASE GSN [online] 7 November 2001 (2001-11-07), XP002237857, Database accession no. AAK83051 * |
DATABASE GSN [online] 7 November 2001 (2001-11-07), XP002237858, Database accession no. AAK87567 * |
DATABASE GSN [online] 7 November 2001 (2001-11-07), XP002237859, Database accession no. AAK83993 * |
DATABASE GSN [online] 7 November 2001 (2001-11-07), XP002237860, Database accession no. AAK82571 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003040369A2 (en) | 2003-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004067570A3 (en) | Prostate cancer diagnosis and treatment | |
TW200736253A (en) | Pyridopyrazine derivatives and their use | |
WO2006127861A3 (en) | Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations | |
WO2004066941A3 (en) | Expression profiles for colon cancer and methods of use | |
WO2009090553A3 (en) | Compositions and methods of detecting post-stop peptides | |
WO2005084109A3 (en) | Cancer specific gene mh15 | |
WO2004089951A8 (en) | Imidazopyridine derivatives having an affinity for melanocortin receptors | |
WO2007141280A3 (en) | Proteins | |
WO2005059108A3 (en) | Gene expression profiles and methods of use | |
WO2008073177A3 (en) | Expression profiles associated with irinotecan treatment | |
WO2009019370A3 (en) | Apolipoprotein aii assay method for the in vitro diagnosis of colorectal cancer | |
WO2004078035A3 (en) | Expression profiles for breast cancer and methods of use | |
WO2004046332A3 (en) | Amplified genes involved in cancer | |
WO2005005661A3 (en) | Genes regulated in ovarian cancer as prognostic and therapeutic targets | |
WO2001071357A3 (en) | Diagnosis and treatment of breast cancer | |
WO2003040369A3 (en) | Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines | |
WO2007071829A3 (en) | Methods and means related to diseases | |
WO2002064731A3 (en) | Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines | |
EP2209000A3 (en) | Detection, monitoring and treatment of cancer | |
WO2003025176A8 (en) | Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines | |
WO2003025175A3 (en) | Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines | |
WO2003004526A3 (en) | Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines | |
WO2008026008A8 (en) | Protein | |
WO2003025177A3 (en) | Sequences involved in phenomena of tumour suppression, tumour reversion, adoptosis and/or resistance to viruses and the use thereof as medicaments | |
WO2002059256A3 (en) | Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |